Literature DB >> 16131838

Mechanisms of tumor suppression by the SCF(Fbw7).

Alex C Minella1, Bruce E Clurman.   

Abstract

SCF ubiquitin ligases regulate the degradation of many proteins involved in the control of cell division and growth. F-box proteins are the SCF components that bind to substrates, and this binding is usually signaled by substrate phosphorylation. The Fbw7/hCdc4 F-box protein was first recognized by its ability to bind cyclin E, and the SCF (Fbw7) is now known to target c-Myc, c-Jun and Notch for degradation in addition to its role in cyclin E proteolysis. Fbw7 thus negatively regulates several key oncoproteins. Accordingly, Fbw7 is a tumor suppressor that is mutated in a wide spectrum of human cancers, and Fbw7 functions as a haploin sufficient tumor suppressor in mice. Because there are three Fbw7 isoforms that reside in different subcellular compartments, as well as multiple Fbw7 substrates that are the products of proto-oncogenes, the mechanisms of tumor suppression by Fbw7 are complex and incompletely understood. In this review we discuss the activities of the SCF(Fbw7) in the context of its role as a tumor suppressor and highlight recent findings demonstrating that dominant oncogenes disable Fbw7 function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131838     DOI: 10.4161/cc.4.10.2058

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  62 in total

1.  GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α.

Authors:  Daniela Flügel; Agnes Görlach; Thomas Kietzmann
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

2.  Linking model systems to cancer therapeutics: the case of Mastermind.

Authors:  Barry Yedvobnick; Ken Moberg
Journal:  Dis Model Mech       Date:  2010-07-27       Impact factor: 5.758

3.  The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.

Authors:  Madhurima Biswas; Diane Phan; Momoko Watanabe; Jefferson Y Chan
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

Review 4.  The two faces of FBW7 in cancer drug resistance.

Authors:  Zhiwei Wang; Hidefumi Fukushima; Daming Gao; Hiroyuki Inuzuka; Lixin Wan; Alan W Lau; Pengda Liu; Wenyi Wei
Journal:  Bioessays       Date:  2011-08-30       Impact factor: 4.345

5.  MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer.

Authors:  Hao Chang; Yue-Hong Liu; Li-Li Wang; Ju Wang; Zhi-Hong Zhao; Jun-Feng Qu; Sheng-Fa Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

Review 6.  Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.

Authors:  Mu-Shui Dai; Yetao Jin; Jayme R Gallegos; Hua Lu
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

7.  MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2.

Authors:  Yetao Jin; Shelya X Zeng; Xiao-Xin Sun; Hunjoo Lee; Christine Blattner; Zhixiong Xiao; Hua Lu
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

8.  Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.

Authors:  Sahoko Matsuoka; Yuichi Oike; Ichiro Onoyama; Atsushi Iwama; Fumio Arai; Keiyo Takubo; Yoichi Mashimo; Hideyuki Oguro; Eriko Nitta; Keisuke Ito; Kana Miyamoto; Hiroki Yoshiwara; Kentaro Hosokawa; Yuka Nakamura; Yumiko Gomei; Hiroko Iwasaki; Yasuhide Hayashi; Yumi Matsuzaki; Keiko Nakayama; Yasuo Ikeda; Akira Hata; Shigeru Chiba; Keiichi I Nakayama; Toshio Suda
Journal:  Genes Dev       Date:  2008-03-26       Impact factor: 11.361

9.  HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53.

Authors:  Yuwen Xue; Jian Chen; Hyun-Ho Choi; Liem Phan; Ping-Chieh Chou; Ruiying Zhao; Huiling Yang; Janice Santiago; Mo Liu; Giselle E Yeung; Sai-Ching J Yeung; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

Review 10.  The role of NOTCH1 signaling in T-ALL.

Authors:  Adolfo A Ferrando
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.